Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Medicinova Inc.
(MNOV US)
$1.40
-0.01
0.36%
Ext:
$1.59
+0.19
13.98%
(Market Closed ยท 00:55:25 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Medicinova Inc.
(MNOV US)
$1.40
-0.01
0.36%
Ext:
$1.59
+0.19
13.98%
(Market Closed ยท 00:55:25 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
EDINET Filings
Financials
Charting
Short Interest
Employees
MNOV US
โ
Ask AI
MNOV US
โ
Ask AI
SEC Filings
SEC Filings
Select Filings
Financials
(90)
Expand
10-Q
Q3
ended 30 Sept 2026
12 Nov
10-Q
Q2
ended 30 Jun 2026
13 Aug
10-Q
Q1
ended 31 Mar 2026
14 May
10-K
FY 2025
ended 31 Dec 2025
10 Mar
10-Q
Q3
ended 30 Sept 2025
12 Nov 2025
10-Q
Q2
ended 30 Jun 2025
14 Aug 2025
10-Q
Q1
ended 31 Mar 2025
13 May 2025
10-K
FY 2024
ended 31 Dec 2024
19 Feb 2025
10-Q
Q3
ended 30 Sept 2024
13 Nov 2024
10-Q
Q2
ended 30 Jun 2024
8 Aug 2024
10-Q
Q1
ended 31 Mar 2024
9 May 2024
10-K
FY 2023
ended 31 Dec 2023
15 Feb 2024
10-Q
Q3
ended 30 Sept 2023
9 Nov 2023
10-Q
Q2
ended 30 Jun 2023
9 Aug 2023
10-Q
Q1
ended 31 Mar 2023
11 May 2023
Events
(277)
Expand
8-K
Entry into a Material Definitive Agreement
28 Sep
8-K
Termination of a Material Definitive Agreement
2 Sep
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
19 Aug
8-K
Submission of Matters to a Vote of Security Holders
24 Jun
8-K
Unaudited Consolidated Financial Results
20 Feb
8-K
Entry into a Material Definitive Agreement
30 Dec 2025
8-K
Entry into Material Agreement
1 Aug 2025
8-K
Submission of Matters to Shareholder Vote
18 Jun 2025
8-K
Regulation FD Disclosure
11 Mar 2025
8-K
Submission of Matters to Shareholder Vote
12 Jun 2024
8-K
Director/Officer Changes & Compensatory Arrangements
7 Aug 2023
8-K
Delisting/Non-Compliance Notice; Listing Transfer
22 Jun 2023
8-K
Submission of Matters to Shareholder Vote
14 Jun 2023
8-K
Director/Officer Changes & Compensatory Arrangements
26 Apr 2023
8-K
Director/Officer Changes & Compensatory Arrangements
21 Jun 2022
Insider Ownership
(295)
Expand
Form 4
3D Opportunity Master Fund
29 Sep
Form 4
Nagao Hideki
25 Jun
Form 4
Lemerond Nicole
25 Jun
Form 4
BEAVER CAROLYN
25 Jun
Form 4
Matsuda Kazuko
20 Jan
Form 4
IWAKI YUICHI
20 Jan
Form 4
Lemerond Nicole
20 Jun 2025
Form 4
Nagao Hideki
20 Jun 2025
Form 4
BEAVER CAROLYN
20 Jun 2025
Form 4
Nagao Hideki
14 Feb 2025
Form 4
Matsuda Kazuko
14 Feb 2025
Form 4
Lemerond Nicole
14 Feb 2025
Form 4
IWAKI YUICHI
14 Feb 2025
Form 4
BEAVER CAROLYN
14 Feb 2025
Form 4
IWAKI YUICHI
10 Jan 2025
Beneficial Ownership
(43)
Expand
SC 13G
MEDICINOVA INC
30 Oct
SC 13D/A
MEDICINOVA INC
29 Sep
SC 13D/A
MEDICINOVA INC
12 Jul 2022
SC 13G/A
MEDICINOVA INC
12 Jul 2021
SC 13G/A
MEDICINOVA INC
29 Jan 2021
SC 13D
MEDICINOVA INC
21 Jan 2021
SC 13G/A
MEDICINOVA INC
5 Feb 2020
SC 13G
MEDICINOVA INC
8 Feb 2019
SC 13G/A
MEDICINOVA INC
17 May 2018
SC 13G/A
MEDICINOVA INC
9 Jan 2018
SC 13D/A
MEDICINOVA INC
14 Jun 2017
SC 13G/A
MEDICINOVA INC
14 Feb 2017
SC 13G
MEDICINOVA INC
30 Jan 2017
SC 13G/A
MEDICINOVA INC
11 Jul 2016
SC 13D/A
MEDICINOVA INC
17 May 2016
Proxies
(54)
Expand
ARS
Annual report to security holders
29 Apr
DEFA14A
Definitive additional materials
29 Apr
DEF 14A
Definitive proxy statement
29 Apr
PRER14A
Preliminary proxy statement (revision)
20 Apr
PRE 14A
Preliminary proxy statement
17 Apr
ARS
Annual report to security holders
28 Apr 2025
DEFA14A
Definitive additional materials
28 Apr 2025
DEF 14A
Definitive proxy statement
28 Apr 2025
DEF 14A
Definitive proxy statement
26 Apr 2024
DEFA14A
Definitive additional materials
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2023
DEFA14A
Definitive additional materials
26 Apr 2023
DEF 14A
Definitive proxy statement
26 Apr 2023
DEF 14A
Definitive proxy statement
26 Apr 2022
Registrations
(82)
Expand
424B5
Prospectus filing (Rule 424(b)(5))
30 Dec 2025
S-3
Registration statement (primary offering)
5 Dec 2025
S-1
Registration statement (general form)
22 Aug 2025
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
424B5
Prospectus filing (Rule 424(b)(5))
30 Sep 2022
S-3
Registration statement (primary offering)
26 Aug 2022
S-8
Registration statement (employee benefit plan)
13 May 2022
424B3
Prospectus filing (Rule 424(b)(3))
12 Feb 2021
S-3
Registration statement (primary offering)
29 Jan 2021
424B5
Prospectus filing (Rule 424(b)(5))
23 Aug 2019
S-3
Registration statement (primary offering)
9 Aug 2019
S-8
Registration statement (employee benefit plan)
21 Jun 2019
Filing Review Correspondence
(10)
Expand
CORRESP
Filing review correspondence
9 Dec 2025
CORRESP
Filing review correspondence
26 Sep 2025
CORRESP
Filing review correspondence
1 Sep 2022
CORRESP
Filing review correspondence
8 Feb 2021
CORRESP
Filing review correspondence
20 Aug 2019
CORRESP
Filing review correspondence
27 Sep 2017
CORRESP
Filing review correspondence
25 Aug 2016
CORRESP
Filing review correspondence
18 Aug 2006
CORRESP
Filing review correspondence
18 Aug 2006
UPLOAD
Filing review upload
15 Aug 2006
SEC Orders And Notices
(14)
Expand
EFFECT
Notice of effectiveness
12 Dec 2025
EFFECT
Notice of effectiveness
30 Sep 2025
EFFECT
Notice of effectiveness
6 Sep 2022
EFFECT
Notice of effectiveness
10 Feb 2021
EFFECT
Notice of effectiveness
22 Aug 2019
EFFECT
Notice of effectiveness
2 Oct 2017
EFFECT
Notice of effectiveness
9 Dec 2016
EFFECT
Notice of effectiveness
29 Aug 2016
EFFECT
Notice of effectiveness
3 Dec 2012
CT ORDER
Confidential treatment order
26 Sep 2011
EFFECT
Notice of effectiveness
16 Dec 2009
EFFECT
Notice of effectiveness
18 Nov 2009
CT ORDER
Confidential treatment order
14 May 2009
EFFECT
Notice of effectiveness
14 Nov 2006
Other
(1)
Expand
CERTNAS
AUTO-GENERATED PAPER DOCUMENT
6 Dec 2006
Select Filings
Financials
(90)
Expand
10-Q
Q3
ended 30 Sept 2026
12 Nov
10-Q
Q2
ended 30 Jun 2026
13 Aug
10-Q
Q1
ended 31 Mar 2026
14 May
10-K
FY 2025
ended 31 Dec 2025
10 Mar
10-Q
Q3
ended 30 Sept 2025
12 Nov 2025
10-Q
Q2
ended 30 Jun 2025
14 Aug 2025
10-Q
Q1
ended 31 Mar 2025
13 May 2025
10-K
FY 2024
ended 31 Dec 2024
19 Feb 2025
10-Q
Q3
ended 30 Sept 2024
13 Nov 2024
10-Q
Q2
ended 30 Jun 2024
8 Aug 2024
10-Q
Q1
ended 31 Mar 2024
9 May 2024
10-K
FY 2023
ended 31 Dec 2023
15 Feb 2024
10-Q
Q3
ended 30 Sept 2023
9 Nov 2023
10-Q
Q2
ended 30 Jun 2023
9 Aug 2023
10-Q
Q1
ended 31 Mar 2023
11 May 2023
Events
(277)
Expand
8-K
Entry into a Material Definitive Agreement
28 Sep
8-K
Termination of a Material Definitive Agreement
2 Sep
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
19 Aug
8-K
Submission of Matters to a Vote of Security Holders
24 Jun
8-K
Unaudited Consolidated Financial Results
20 Feb
8-K
Entry into a Material Definitive Agreement
30 Dec 2025
8-K
Entry into Material Agreement
1 Aug 2025
8-K
Submission of Matters to Shareholder Vote
18 Jun 2025
8-K
Regulation FD Disclosure
11 Mar 2025
8-K
Submission of Matters to Shareholder Vote
12 Jun 2024
8-K
Director/Officer Changes & Compensatory Arrangements
7 Aug 2023
8-K
Delisting/Non-Compliance Notice; Listing Transfer
22 Jun 2023
8-K
Submission of Matters to Shareholder Vote
14 Jun 2023
8-K
Director/Officer Changes & Compensatory Arrangements
26 Apr 2023
8-K
Director/Officer Changes & Compensatory Arrangements
21 Jun 2022
Insider Ownership
(295)
Expand
Form 4
3D Opportunity Master Fund
29 Sep
Form 4
Nagao Hideki
25 Jun
Form 4
Lemerond Nicole
25 Jun
Form 4
BEAVER CAROLYN
25 Jun
Form 4
Matsuda Kazuko
20 Jan
Form 4
IWAKI YUICHI
20 Jan
Form 4
Lemerond Nicole
20 Jun 2025
Form 4
Nagao Hideki
20 Jun 2025
Form 4
BEAVER CAROLYN
20 Jun 2025
Form 4
Nagao Hideki
14 Feb 2025
Form 4
Matsuda Kazuko
14 Feb 2025
Form 4
Lemerond Nicole
14 Feb 2025
Form 4
IWAKI YUICHI
14 Feb 2025
Form 4
BEAVER CAROLYN
14 Feb 2025
Form 4
IWAKI YUICHI
10 Jan 2025
Beneficial Ownership
(43)
Expand
SC 13G
MEDICINOVA INC
30 Oct
SC 13D/A
MEDICINOVA INC
29 Sep
SC 13D/A
MEDICINOVA INC
12 Jul 2022
SC 13G/A
MEDICINOVA INC
12 Jul 2021
SC 13G/A
MEDICINOVA INC
29 Jan 2021
SC 13D
MEDICINOVA INC
21 Jan 2021
SC 13G/A
MEDICINOVA INC
5 Feb 2020
SC 13G
MEDICINOVA INC
8 Feb 2019
SC 13G/A
MEDICINOVA INC
17 May 2018
SC 13G/A
MEDICINOVA INC
9 Jan 2018
SC 13D/A
MEDICINOVA INC
14 Jun 2017
SC 13G/A
MEDICINOVA INC
14 Feb 2017
SC 13G
MEDICINOVA INC
30 Jan 2017
SC 13G/A
MEDICINOVA INC
11 Jul 2016
SC 13D/A
MEDICINOVA INC
17 May 2016
Proxies
(54)
Expand
ARS
Annual report to security holders
29 Apr
DEFA14A
Definitive additional materials
29 Apr
DEF 14A
Definitive proxy statement
29 Apr
PRER14A
Preliminary proxy statement (revision)
20 Apr
PRE 14A
Preliminary proxy statement
17 Apr
ARS
Annual report to security holders
28 Apr 2025
DEFA14A
Definitive additional materials
28 Apr 2025
DEF 14A
Definitive proxy statement
28 Apr 2025
DEF 14A
Definitive proxy statement
26 Apr 2024
DEFA14A
Definitive additional materials
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2024
ARS
Annual report to security holders
26 Apr 2023
DEFA14A
Definitive additional materials
26 Apr 2023
DEF 14A
Definitive proxy statement
26 Apr 2023
DEF 14A
Definitive proxy statement
26 Apr 2022
Registrations
(82)
Expand
424B5
Prospectus filing (Rule 424(b)(5))
30 Dec 2025
S-3
Registration statement (primary offering)
5 Dec 2025
S-1
Registration statement (general form)
22 Aug 2025
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
S-8 POS
Post-effective amendment (employee benefit plan)
19 Jan 2024
424B5
Prospectus filing (Rule 424(b)(5))
30 Sep 2022
S-3
Registration statement (primary offering)
26 Aug 2022
S-8
Registration statement (employee benefit plan)
13 May 2022
424B3
Prospectus filing (Rule 424(b)(3))
12 Feb 2021
S-3
Registration statement (primary offering)
29 Jan 2021
424B5
Prospectus filing (Rule 424(b)(5))
23 Aug 2019
S-3
Registration statement (primary offering)
9 Aug 2019
S-8
Registration statement (employee benefit plan)
21 Jun 2019
Filing Review Correspondence
(10)
Expand
CORRESP
Filing review correspondence
9 Dec 2025
CORRESP
Filing review correspondence
26 Sep 2025
CORRESP
Filing review correspondence
1 Sep 2022
CORRESP
Filing review correspondence
8 Feb 2021
CORRESP
Filing review correspondence
20 Aug 2019
CORRESP
Filing review correspondence
27 Sep 2017
CORRESP
Filing review correspondence
25 Aug 2016
CORRESP
Filing review correspondence
18 Aug 2006
CORRESP
Filing review correspondence
18 Aug 2006
UPLOAD
Filing review upload
15 Aug 2006
SEC Orders And Notices
(14)
Expand
EFFECT
Notice of effectiveness
12 Dec 2025
EFFECT
Notice of effectiveness
30 Sep 2025
EFFECT
Notice of effectiveness
6 Sep 2022
EFFECT
Notice of effectiveness
10 Feb 2021
EFFECT
Notice of effectiveness
22 Aug 2019
EFFECT
Notice of effectiveness
2 Oct 2017
EFFECT
Notice of effectiveness
9 Dec 2016
EFFECT
Notice of effectiveness
29 Aug 2016
EFFECT
Notice of effectiveness
3 Dec 2012
CT ORDER
Confidential treatment order
26 Sep 2011
EFFECT
Notice of effectiveness
16 Dec 2009
EFFECT
Notice of effectiveness
18 Nov 2009
CT ORDER
Confidential treatment order
14 May 2009
EFFECT
Notice of effectiveness
14 Nov 2006
Other
(1)
Expand
CERTNAS
AUTO-GENERATED PAPER DOCUMENT
6 Dec 2006
Ask in Filing
Ask in Filing